
Oric Pharmaceuticals Inc is a biotechnology business based in the US. Oric Pharmaceuticals Inc stocks (ORIC.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $17.79 – an increase of 4.77% over the previous week. Oric Pharmaceuticals Inc employs 88 staff and has a market cap (total outstanding stock value) of $232.2 million.
How to buy Oric Pharmaceuticals Inc stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ORIC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Oric Pharmaceuticals Inc?
- Oric Pharmaceuticals Inc shares summary
- Compare share dealing platforms
- Is Oric Pharmaceuticals Inc stock a buy or sell?
- Oric Pharmaceuticals Inc performance over time
- Oric Pharmaceuticals Inc's financials
- How volatile are Oric Pharmaceuticals Inc shares?
- Does Oric Pharmaceuticals Inc pay a dividend?
- Other common questions
Oric Pharmaceuticals Inc stock price (NASDAQ:ORIC)
Use our graph to track the performance of ORIC stocks over time.Oric Pharmaceuticals Inc shares at a glance
Latest market close | $5.27 |
---|---|
52-week range | $2.36 - $6.85 |
50-day moving average | $5.25 |
200-day moving average | $4.40 |
Wall St. target price | $13.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.16 |
Buy Oric Pharmaceuticals Inc stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Oric Pharmaceuticals Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Oric Pharmaceuticals Inc price performance over time
Historical closes compared with the close of $5.27 from 2023-06-01
1 week (2023-05-26) | 4.77% |
---|---|
1 month (2023-05-03) | 1.74% |
3 months (2023-03-03) | 16.85% |
6 months (2022-12-02) | 25.48% |
1 year (2022-06-02) | 60.67% |
---|---|
2 years (2021-06-02) | -75.49% |
3 years (2020-06-03) | 35.88 |
5 years (2018-05-30) | N/A |
Oric Pharmaceuticals Inc financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -22.22% |
Return on equity TTM | -39.44% |
Profit margin | 0% |
Book value | $4.50 |
Market capitalisation | $232.2 million |
TTM: trailing 12 months
Oric Pharmaceuticals Inc share dividends
We're not expecting Oric Pharmaceuticals Inc to pay a dividend over the next 12 months.
Oric Pharmaceuticals Inc share price volatility
Over the last 12 months, Oric Pharmaceuticals Inc's shares have ranged in value from as little as $2.36 up to $6.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oric Pharmaceuticals Inc's is 0.4768. This would suggest that Oric Pharmaceuticals Inc's shares are less volatile than average (for this exchange).
Oric Pharmaceuticals Inc overview
ORIC Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. ORIC Pharmaceuticals, Inc. has a license and collaboration agreement with Voronoi Inc. ; a license agreement with Mirati Therapeutics, Inc.
Stocks similar to Oric Pharmaceuticals Inc
Oric Pharmaceuticals Inc in the news
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
-
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
-
How to buy Arbitrum (ARB) in Canada
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
-
How to buy SSV Network (SSV) in Canada
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
-
How to buy USDD (USDD) in Canada
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
-
How to buy Blur (BLUR) in Canada
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
-
How to buy FLOKI Inu (FLOKI) in Canada
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
-
How to buy Aptos (APT) in Canada
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
-
How to buy EthereumPoW (ETHW) in Canada
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
-
How to buy Coinbase Wrapped Staked ETH (CBETH) in Canada
This guide provides step-by-step instructions on how to buy Coinbase Wrapped Staked ETH, lists some exchanges where you can get it and provides daily price data on (CBETH).